AC
AUGX

Aristides Capital’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Aristides Capital’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-60,000
Closed -$289K – 216
2023
Q2 		$289K Buy
+60,000
New +$208K 0.12% 111

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Aristides Capital's AUGX Position: Q3 2023 in Review

Aristides Capital sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2023, closing a stake of 60,000 shares — an estimated $289K sold.

Aristides Capital first reported a position in AUGX in Q2 2023 and held it in 1 quarter. The position peaked at $289K in Q2 2023. 64 funds tracked by Wall St. Rank hold AUGX as of Q3 2023.

  • Aristides Capital reported no remaining Augmedix, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Aristides Capital sold 60,000 Augmedix, Inc. Common Stock shares in Q3 2023, an estimated $289K.
  • Aristides Capital first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Aristides Capital's Augmedix, Inc. Common Stock position peaked at $289K in Q2 2023.
  • 64 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2023.

Based on Aristides Capital's 13F filing for Q3 2023, filed 14 Nov 2023.